Baird Reiterates an 'Outperform' on Onyx Pharmaceuticals (ONXX); Kyprolis Uptake and Take-out Potential
Tweet
Share
E-mailGet Alerts ONXX Hot Sheet
Price: $124.70 --0%
Rating Summary:
9 Buy, 12 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
9 Buy, 12 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Baird reiterates an 'Outperform' on Onyx Pharmaceuticals (NASDAQ: ONXX) price target of $80.00.
Analyst, Christopher Raymond, said, "Remain buyers following ONXX's relatively uneventful quarter. While expense guidance was raised meaningfully, we think investors will largely look past this as this name will trade primarily on Kyprolis uptake, which we continue to think will be robust. Combining this with what we see as real take-out potential, we remain buyers into the $80 range."
"For our part, we model $2M and $15M in Kyprolis sales for Q312 and Q412, respectively."
For an analyst ratings summary and ratings history on Onyx Pharmaceuticals click here. For more ratings news on Onyx Pharmaceuticals click here.
Shares of Onyx Pharmaceuticals closed at $73.13 yesterday.
Analyst, Christopher Raymond, said, "Remain buyers following ONXX's relatively uneventful quarter. While expense guidance was raised meaningfully, we think investors will largely look past this as this name will trade primarily on Kyprolis uptake, which we continue to think will be robust. Combining this with what we see as real take-out potential, we remain buyers into the $80 range."
"For our part, we model $2M and $15M in Kyprolis sales for Q312 and Q412, respectively."
For an analyst ratings summary and ratings history on Onyx Pharmaceuticals click here. For more ratings news on Onyx Pharmaceuticals click here.
Shares of Onyx Pharmaceuticals closed at $73.13 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
- Wolverine World Wide (WWW) PT Raised to $31 at UBS on Growth, EPS Upside Potential
- Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Trader TalkRelated Entities
Robert W BairdSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
